Skip to content
OpenCapital
Get started

ADC Therapeutics ADCT Q2 2025 earnings

Reported August 12, 2025 · Before market open

Revenue$18.8MBeat by $645.5K
EPS-$0.50Miss by $0.14
Revenue estimate$18.2M
EPS estimate-$0.36

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$18.9M
EPS estimate-$0.19

Versus estimates

Revenue

Q1 2026$20.9MBeat by $864.2KQ4 2025$23.1MBeat by $757.8KQ3 2025$16.4MMiss by $5.1M
Q2 2025$18.8MBeat by $645.5K
Q1 2025$23.0MBeat by $5.5MQ4 2024$16.9MMiss by $2.1M

Diluted EPS

Q1 2026-$0.21Miss by $0.02Q4 2025-$0.04Beat by $0.28Q3 2025-$0.30Beat by $0.10
Q2 2025-$0.50Miss by $0.14
Q1 2025-$0.36Beat by $0.02Q4 2024-$0.29Beat by $0.06

Ask the moment ADC Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did ADC Therapeutics report Q2 2025 earnings?
ADC Therapeutics (ADCT) reported Q2 2025 earnings on August 12, 2025 before market open.
What were ADC Therapeutics's Q2 2025 revenue and EPS?
ADC Therapeutics reported revenue of $18.8M and eps of $-0.50 for Q2 2025.
Did ADC Therapeutics beat estimates in Q2 2025?
Revenue beat the consensus estimate of $18.2M by $645.5K. EPS missed the consensus estimate of $-0.36 by $0.14.
How did ADC Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.2% from $17.4M a year earlier and eps declined 31.6% from $-0.38.
Where can I find ADC Therapeutics's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001771910-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.